| Course | DNRS 6630 Psychopharmacologic Approaches to Treatment of Psychopathology |
|---|---|
| Week | Week 3 |
| Paper type | Case vignette response |
| Length | About 510 words, 4 pages |
| Format | APA 7 student paper |
| School | Walden University |
| Program | Doctor of Nursing Practice (DNP) |
| Updated | October 2026 |
Free sample paper for DNRS 6630 Week 3
Vignette Response: Eight Months of Worry in a 31-Year-Old Woman, and What the Case Does Not Tell Us
Student Name
College of Nursing, Walden University
DNRS 6630: Psychopharmacologic Approaches to Treatment of Psychopathology
Instructor Name
Month Day, Year
Vignette Response: Eight Months of Worry in a 31-Year-Old Woman, and What the Case Does Not Tell Us
Facts kept. A 31-year-old woman has had 8 months of excessive, hard-to-control worry about work and her health, with poor sleep, muscle tension, and irritability. Her GAD-7 score is 15, in the severe range on the instrument's cut points (Spitzer et al., 2006). She missed 4 workdays last month. She denies thoughts of self-harm, drinks alcohol rarely, and has never taken a psychotropic medicine. Set aside: her job title, her recent move, and her preference for morning appointments, which matter for the relationship but not for this decision.
What the case does not establish. Four gaps stand out. Whether she might become pregnant in the next year would change the answer, because it shapes which evidence applies. Whether she has ever had a period of elevated mood or reduced need for sleep would change the answer, since a mood-elevating response to treatment is a risk if she has. Her thyroid function would change the answer if it were abnormal, because thyroid overactivity can mimic anxiety. Her caffeine intake would not change the choice, though it belongs in the education.
The choice, at the level of a class, assuming the three decisive gaps come back clear, is a serotonin reuptake inhibitor, alongside a referral for cognitive behavioral therapy, which has placebo-controlled evidence in generalized anxiety disorder (Carpenter et al., 2018). The alternative I defend against is a benzodiazepine. In a network meta-analysis of 89 trials, several reuptake inhibitors were more effective than placebo with relatively good acceptability, while benzodiazepines were effective but poorly tolerated compared with placebo (Slee et al., 2019). For a chronic condition of 8 months, a class that is well tolerated and does not carry the risks of dependence and sedation with long-term use is the better fit. A benzodiazepine would work faster, and that is its real appeal; she is distressed now. That advantage is weighed openly with her rather than dismissed, and the trade is explained: slower relief in exchange for a treatment she can stay on safely.
Monitoring. The clinic nurse calls at 2 weeks to ask about side effects, sleep, and any thoughts of self-harm. I repeat the GAD-7 at 4 and 8 weeks and ask the same safety and mood-elevation questions at each visit. She records missed workdays each month. She is told in advance that benefit usually builds over several weeks while early side effects tend to ease, so that a quiet first fortnight is not read as failure. Results are recorded in her chart as scores, not impressions, so that the 8-week decision can be checked by anyone who reads it.
The observation that would end this trial is a GAD-7 score that has fallen by fewer than 5 points after 8 weeks at a tolerated dose, or any sign of elevated mood, or side effects she is not willing to continue with. Any one of these ends the trial, and the next step is chosen with her then.
References
Carpenter, J. K., Andrews, L. A., Witcraft, S. M., Powers, M. B., Smits, J. A. J., & Hofmann, S. G. (2018). Cognitive behavioral therapy for anxiety and related disorders: A meta-analysis of randomized placebo-controlled trials. Depression and Anxiety, 35(6), 502-514. https://doi.org/10.1002/da.22728
Slee, A., Nazareth, I., Bondaronek, P., Liu, Y., Cheng, Z., & Freemantle, N. (2019). Pharmacological treatments for generalised anxiety disorder: A systematic review and network meta-analysis. The Lancet, 393(10173), 768-777. https://doi.org/10.1016/S0140-6736(18)31793-8
Spitzer, R. L., Kroenke, K., Williams, J. B. W., & Löwe, B. (2006). A brief measure for assessing generalized anxiety disorder: The GAD-7. Archives of Internal Medicine, 166(10), 1092-1097. https://doi.org/10.1001/archinte.166.10.1092
The Walden DNRS 6630 Week 3 instructions
In the third week, sections commonly provide a short case vignette and ask for a structured response. You identify the key facts, note what information is missing and why it matters, propose a working diagnosis or formulation, and outline initial treatment considerations with evidence. Many prompts ask you to justify the assessment tools and scores you rely on. Expect a brief document of about two pages with APA 7 citations. The response should stay within what the vignette supports, labeling assumptions clearly. Some instructors want the reasoning organized under set headings such as facts, gaps and plan. Cite validation studies for any screening instrument you interpret, and give the score range the instrument's authors used.
Inside the DNRS 6630 Week 3 example
Five paragraphs fill a page. The first keeps only the facts bearing on a decision and states which were set aside, a move most responses skip entirely. The second lists what the case does not establish and marks which of those gaps would change the answer, separating them from the ones that would not. The third states the choice at the level of a class and defends it against one named alternative rather than against every option available. The fourth commits to monitoring, written as what gets checked, at what interval, and by whom. The fifth names the observation that would end the trial. No product name, amount or titration sequence appears anywhere on this page.
Reading the DNRS 6630 Week 3 rubric
The gaps paragraph is where this assignment is usually won or lost. A response listing every absent detail without saying which ones matter reads as hedging, while one naming two gaps and their consequences shows judgment a marker can credit. Defending a choice against a real alternative earns more than restating the choice with additional adjectives. Monitoring written as a general intention costs across two areas at once, since it damages both the plan and the reasoning that produced it. Guidance material cited at the point of decision earns where a tertiary reference does not. Markers also read for whether the response respects the boundary of the case, and answers importing facts the vignette never supplied lose accuracy credit quickly.
DNRS 6630 Week 3 help: mistakes that cost marks
Vignette responses lose the most credit in the gaps section, either by listing every absent detail or by skipping the section. Name the few missing facts that would change your plan and say how. Another mistake is diagnosing from the screening score alone; a GAD-7 suggests severity, not a diagnosis. Students also jump to a medication before ruling out medical causes, substance use or a coexisting mood disorder. Keep assumptions labeled so the grader can see what comes from the vignette. Avoid long drug summaries that the prompt did not ask for. Make sure the score and its severity band match the original validation study. End with the first question you would put to her at follow-up.
Get a DNRS 6630 Week 3 example written to your instructions
Forward the vignette itself along with the response format your section requires and the length it sets, and a reply built to that format comes back to you. The first custom one costs nothing and arrives inside 24 to 48 hours. Whatever you observed on placement remains yours to describe, and the log you keep for it is not something this desk touches.
More DNRS 6630 papers and DNP samples
- DNRS 6630 Week 1: Discussion Post
- DNRS 6630 Week 2: Mechanism Brief
- DNRS 6630 Week 4: Drug class comparison
- DNRS 6630 Week 5: Discussion post
- DNRS 6630 Week 6: Treatment plan
- DNRS 6630 Week 7: Interaction analysis
- DNRS 6630 Week 8: Literature appraisal
- DNRS 6630 Week 9: Special populations paper
- DNRS 6630 Week 10: Integrated case paper
- DNRS 6630 Week 11: Reflection
- DNRS 6800 Week 3: Milestone analysis
- DNRS 6211 Week 3: Budget Worksheet
- NURS 8002 Week 3: DNP essentials gap map
- NURS 8750 Week 3: Aim Consistency Memo
DNRS 6630 Week 3 questions, answered
Is the person in the vignette real?
No. That case was constructed for this page so the response had something specific to work against, and every detail in it was chosen to make the reasoning visible rather than to describe anybody. Your section supplies its own vignette, which replaces this one entirely. What travels between them is the order the paragraphs run in and the discipline of naming gaps first.
Why does the page show no medication details?
Because a public sample library is the wrong place for prescribing content, and because it would add nothing to what the page is for. The reasoning shape is what transfers: which paragraph carries the uncertainty, where the defense sits, and what monitoring has to specify. The clinical particulars belong in a classroom where a supervising prescriber can see them.
How long is a vignette response usually?
This one fills a page, which is where most prompts of the kind land, though sections differ and some ask for considerably more. Nothing published fixes a length for the week. Read the instructions in your classroom for both a word range and whether references are counted inside it, since that second detail changes how much room the argument actually has.
Where can I find a free DNRS 6630 Week 3 sample paper?
The full vignette response on the 31-year-old woman with eight months of worry is on this page, including the facts kept, the gaps and the provisional formulation.
What does a GAD-7 score of 15 mean in DNRS 6630 Week 3?
It falls in the severe range on the instrument's original cut points. The example treats it as a measure of symptom burden that still needs a clinical interview to confirm a diagnosis.